Compound index

Incretin & Metabolic Receptor Agonists

Tirzepatide

Also known as Mounjaro · Zepbound

FDA-approved for specific indicationsFDA-approved

Last reviewed: 2026-11-19

History

Eli Lilly researchers reported discovery of LY3298176 in 2018; initial FDA approval was in 2022.

Key sources

Targeted current-label and chronology check: November 19, 2026. Initial adult approval and later pediatric/cardiovascular expansions are distinct; trial summaries are not an exhaustive systematic review.

Related compounds

  • Retatrutide

    Same scientific class · A 39-amino-acid chain. · Late-stage human trials

  • Semaglutide

    Same scientific class · A 31-amino-acid chain. · FDA-approved for specific indications

Related glossary terms